Cryogenic PPE - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The cryogenic PPE market is projected to expand from USD 255.47 million in 2025 and USD 271.55 million in 2026 to USD 376.06 million by 2031, registering a CAGR of 6.73% between 2026 and 2031. This report is segmented by Product Type (Cryogenic Gloves, Face Shields, Aprons and Lab Coats, Integrated PPE Kits), Application (Biobanking and Stem Cells, Vaccine and Biologic Storage, and More), End-User (Hospitals, Clinical Research Laboratories, and More), and Geography (North America, Europe, Asia-Pacific, Rest of the World). The Market Forecasts are Provided in Terms of Value (USD).

Global Cryogenic PPE Market Trends and Insights

Growth in Biobanking and Cell Therapy Adoption

Biobanking expansion is the strongest demand driver for the cryogenic PPE market. Multi-site cell and gene therapy trials require controlled cryopreservation from collection through processing and storage. Each liquid nitrogen handling point requires formal protective procedures. In June 2026, Cryoport’s IntegriCell service was selected by Verismo Therapeutics to support Phase 1 KIR-CAR T-cell therapy programs. The work covers GMP-compliant cryopreservation for leukapheresis starting material, where documented protective practices form part of the operating environment.As more programs move across distributed clinical sites, protective equipment changes from an occasional purchase into a planned operating requirement.

Expansion of Cryogenic Vaccine Storage Infrastructure

Vaccine cold-chain expansion creates a separate source of demand for the cryogenic PPE market. New distribution hubs place advanced cold storage and handling activities in more locations. The GSK and Abu Dhabi Department of Health partnership opened the region’s first centralized vaccine distribution hub in 2026. The hub is designed to handle more than 20 vaccine types and distribute millions of doses across a network reaching from the Gulf to sub-Saharan Africa. Facilities adding cryogenic capability need worker protection at the same time as they install storage and handling processes. This creates an opening for suppliers that can support first-time buyers with product selection, training material, and dependable local distribution.

High Cost of Advanced Cryogenic PPE

Advanced cryogenic assemblies remain expensive for many healthcare facilities. Multi-layer kits may include compliant gloves, aluminized face shields, cryogenic aprons, waterproof liners, and thermal construction. These designs require specialized materials and manufacturing processes that limit low-cost substitution. Smaller hospitals, independent laboratories, and biobanks may instead buy general-purpose gloves despite the different risk posed by liquid nitrogen at -196°C. Price pressure is strongest in South America, parts of Southeast Asia, and sub-Saharan Africa, where safety budgets are often not planned in advance. The cryogenic PPE market, therefore, faces slower uptake for integrated kits where procurement decisions are led primarily by unit price.

Other drivers and restraints analyzed in the detailed report include:

• Rising Safety Regulations in Clinical Labs
• Increasing Radiopharmaceutical Demand
• Limited Awareness in Smaller Healthcare Facilities

Segment Analysis

Cryogenic gloves captured 40.13% of revenue in 2025 and remained the largest product category in the cryogenic PPE market. They are used across cryogen transfer, storage, sample handling, and related laboratory tasks. Berkeley Lab and Cornell University both identify cryogenic gloves as essential protection for work involving cryogenic liquids. Face shields, aprons, lab coats, and related products often follow as facilities develop fuller protection requirements.

Integrated PPE kits are projected to post the highest product type CAGR at 7.11% through 2031. These kits combine several items into a single documented solution for buyers managing complex safety requirements. Hospitals and biobanking facilities can use kits to simplify product selection and compliance records. Consolidating several protective items under fewer stock-keeping units can also reduce administrative work for group purchasing organizations. The Cryogenic PPE industry is likely to see kit demand strengthen where institutions standardize procedures across multiple sites.

Complete Report Scope:

• By Product Type
  • Cryogenic Gloves
  • Face Shields
  • Aprons and Lab Coats
  • Integrated PPE Kits
• By Application
  • Biobanking and Stem Cells
  • Vaccine and Biologic Storage
  • Clinical Labs and Pathology
  • Radiopharmaceuticals and Isotopes
  • Other Applications
• By End-User
  • Hospitals and Surgical Centers
  • Clinical Research Laboratories
  • Biopharma Manufacturing Facilities
  • Other End-Users
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World

Geography Analysis

North America held 47.23% of revenue in 2025 and represented the largest geographic share of the cryogenic PPE market. The region has a large concentration of regulated biopharma manufacturing, biobanks, and cell therapy trial sites. Procurement is closely tied to facility compliance reviews and internal safety procedures. The United States provides a substantial base of activity through its clinical research and biologics infrastructure. Canada adds demand through publicly funded biobanking programs, while Mexico’s pharmaceutical contract manufacturing sector is creating new handling environments.

Europe remains a major regulated market for cryogenic protection. EU personal protective equipment requirements and EN standards shape product access and buyer specifications. Germany and the United Kingdom are important procurement centers for hospitals and pharmaceutical manufacturing. Aenova announced in June 2025 that it was adding a cold-chain warehouse at its sterile site in Latina, Italy, with full operational readiness expected in the first quarter of 2026. These additions expand the number of locations that require controlled cold-chain handling and supporting protection.

Asia-Pacific is forecasted to grow at an 8.22% CAGR through 2031, the highest regional rate in the cryogenic PPE market. China and India are investing in biobanking capacity, while Japan, South Korea, and Australia support demand through radiopharmaceutical, plasma, and clinical research activity. In the Rest of the World (RoW) market, comprising regions such as the Middle East and Africa, Grifols strengthened plasma infrastructure development by committing an additional EUR 180 million (USD 195.3 million) to its plasma processing and logistics project in Egypt, with the first phase expected to be operational by October 2026. South America remains the smallest regional base, with demand concentrated in Brazil’s pharmaceutical manufacturing sector and Argentina’s biomedical institutions. Cost-sensitive purchasing and limited access to certified distribution continue to restrict adoption there.

List of Companies Covered in this Report:

• Abdos Labtech Pvt. Ltd.
• Ansell Healthcare
• Core Safety Group
• Cryokit
• Delta Plus Group
• Dragerwerk
• HiCare Protective Wear Pvt. Ltd.
• Honeywell Safety Products
• Inovet Healthcare
• Kimberly-Clark Professional
• Lakeland Industries, Inc.
• MAPA Professional
• MCR Safety
• Najmi Health Care
• National Safety Apparel (NSA)
• Sarvam Safety Equipment Pvt. Ltd.
• Speciality Safety Engineers
• Super Safety Services
• Tempshield Cryo-Protection
• Unique Safety Services

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support